🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Baxter International Inc (BAX)

Vienna
Currency in EUR
29.24
-0.38(-1.28%)
Closed
BAX Scorecard
Full Analysis
Has raised its dividend for 7 consecutive years
Trading near 52-week Low
Fair Value
Day's Range
29.1529.58
52 wk Range
29.1540.63
Key Statistics
Edit
Bid/Ask
29.10 / 29.38
Prev. Close
29.61
Open
29.58
Day's Range
29.15-29.58
52 wk Range
29.15-40.63
Volume
-
Average Volume (3m)
263
1-Year Change
-13.42%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BAX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
40.69
Upside
+34.20%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Baxter International Inc Company Profile

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company’s products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Compare BAX to Peers and Sector

Metrics to compare
BAX
Peers
Sector
Relationship
P/E Ratio
130.1x−0.3x−0.6x
PEG Ratio
−1.35−0.010.00
Price/Book
2.0x1.3x2.6x
Price / LTM Sales
1.0x0.5x3.2x
Upside (Analyst Target)
-453.9%45.4%
Fair Value Upside
Unlock48.6%7.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.212
Dividend Yield
2.18%
Industry Median 0.91%
Annualized payout
0.6446
Paid quarterly
5-Years Growth
+7.18%
Growth Streak

People Also Watch

82.99
MET
-0.28%
28.20
CAG
+0.46%
180.14
TFX
-1.73%
104.52
AFL
+0.13%

FAQ

What Is the Baxter (BAX) Stock Price Today?

The Baxter stock price today is 29.24

What Stock Exchange Does Baxter Trade On?

Baxter is listed and trades on the Vienna stock exchange.

What Is the Stock Symbol for Baxter?

The stock symbol for Baxter is "BAX."

Does Baxter Pay Dividends? What’s The Current Dividend Yield?

The Baxter International Inc dividend yield is 2.21%.

What Is the Baxter Market Cap?

As of today, Baxter market cap is 14.78B.

What is Baxter Earnings Per Share?

The Baxter EPS is 0.212.

From a Technical Analysis Perspective, Is BAX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.